Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 12.35 | N/A |
| PEG Ratio (TTM) | -0.44 | N/A |
| P/S Ratio (TTM) | 0.76 | N/A |
| P/B Ratio (TTM) | 0.82 | N/A |
| P/FCF Ratio (TTM) | -10.55 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.74% | N/A |
| ROE (TTM) | 8.26% | N/A |
| Net Profit Margin (TTM) | 5.46% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (23%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 4.72% | N/A | N/A |
| Revenue | 1.42% | N/A | N/A |
| Net Income | 5.04% | N/A | N/A |
| Cash Flow | 90.17% | N/A | N/A |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.32 | N/A |
| Quick Ratio (TTM) | 0.99 | N/A |
| D/E Ratio (TTM) | 0.36 | N/A |
| Interest Coverage (TTM) | 7.96 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.78 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |